Immediate-access Arteriovenous Versus Standard Arteriovenous Grafts in Hemodialysis Patients
- Conditions
- Hemodialysis Access Failure
- Interventions
- Procedure: Arteriovenous Grafts
- Registration Number
- NCT04388397
- Lead Sponsor
- Egyptian Biomedical Research Network
- Brief Summary
Arteriovenous fistulae (AVF) are considered the main access for hemodialysis (HD). Arteriovenous grafts (AVGs) are an alternative access modality in patients with exhausted native venous access. Immediate-access arteriovenous grafts (IAAVGs) is a new modality in which dialysis can be started immediately to avoid complications of central venous catheters.
- Detailed Description
The study aimed to evaluate and compare patency rate and complications of standard arteriovenous grafts (SAVGs) and immediate-access arteriovenous grafts (IAAVGs) in end stage renal disease (ESRD) patients for one year after the intervention. Patients were randomly divided into two groups: SAVGs group and IAAVGs group. Patients with ESRD with no chance for native AVF were examined clinically and by duplex ultrasonography preoperatively. Follow up was for one year. Primary end points were the success rate, complications rate (hematoma, pseudo-aneurysm, graft site infection, systemic bacteremia), time of first cannulation. Secondary end points were primary and secondary patency within one year.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 477
- Adult hemodialysis patients
- Significant cardiorespiratory comorbidities.
- Peripheral vascular disease.
- Pregnancy or lactation.
- Severe bleeding disorders.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Immediate-access Arteriovenous Grafts Arteriovenous Grafts Immediate-access Arteriovenous Grafts as a vascular access for hemodialysis patients Standard Arteriovenous Grafts Arteriovenous Grafts Standard Arteriovenous Grafts as a vascular access for hemodialysis patients
- Primary Outcome Measures
Name Time Method Success rate 24 hours successful graft procedure
Primary Patency 1 year Patency of hemodialysis access
- Secondary Outcome Measures
Name Time Method Complications rate 1 year Any graft complications
Trial Locations
- Locations (2)
Faculty of Medicine
🇪🇬Zagazig, Egypt
Faculty of Medicine, Zagazig University
🇪🇬Zagazig, Egypt